Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on LinkedIn:
” Mark your calendars, American Association for Cancer Research Annual Meeting (AACR26), San Diego, CA.
Thrilled to co-chair the ‘Advances in PrecisionOncology‘ Clinical Trials Mini Symposium at AACR2026 alongside Jia Jenny Liu from Australia.
- THE PRIME LOCATION- Hall H – Ground Level, Convention Center
- April 21 | 2:30–4:30 PM
Presenting a buffet of the latest and greatest in precision oncology targets/clinical trials.
- ALK/ ROS1/HER2/EGFR/KRAS/ PSMA/FR-α
- In-person or virtual- don’t miss it!
Please ask LIVE Q & A OncoAlert OncoDaily Rick Buck, Elizabeth McKenna, Margaret Foti, Lillian Siu
Link.”
Other Articles Featuring Vivek Subbiah on OncoDaily.